These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30550602)

  • 1. Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality.
    Casas-Mendez F; Abadías MJ; Yuguero O; Bardés I; Barbé F; de Batlle J
    PLoS One; 2018; 13(12):e0208847. PubMed ID: 30550602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, treatment, disposition and outcome of patients with acute exacerbation of COPD presenting to emergency departments in Australia and South East Asia: An AANZDEM study.
    Kelly AM; Holdgate A; Keijzers G; Klim S; Graham CA; Craig S; Kuan WS; Jones P; Lawoko C; Laribi S
    Respirology; 2018 Jul; 23(7):681-686. PubMed ID: 29394524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.
    Bartels W; Adamson S; Leung L; Sin DD; van Eeden SF
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1647-1654. PubMed ID: 29872284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Are There Significant Differences Between Hospitalized and Emergency Department Patients?
    Saint-Pierre MD
    Int J Chron Obstruct Pulmon Dis; 2024; 19():133-138. PubMed ID: 38249827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease presenting to hospital: a generalisable clinical audit.
    Soltani A; Reid D; Wills K; Walters EH
    Intern Med J; 2015 Sep; 45(9):925-33. PubMed ID: 26010582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study.
    Schmidt SA; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Sørensen HT; Christiansen CF
    BMJ Open; 2014 Dec; 4(12):e006720. PubMed ID: 25526796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.
    Estirado C; Ceccato A; Guerrero M; Huerta A; Cilloniz C; Vilaró O; Gabarrús A; Gea J; Crisafulli E; Soler N; Torres A
    Respir Res; 2018 Jun; 19(1):119. PubMed ID: 29907113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.
    Kiser TH; Allen RR; Valuck RJ; Moss M; Vandivier RW
    Am J Respir Crit Care Med; 2014 May; 189(9):1052-64. PubMed ID: 24617842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between blood eosinophil percent and bacterial infection in acute exacerbation of chronic obstructive pulmonary disease.
    Choi J; Oh JY; Lee YS; Hur GY; Lee SY; Shim JJ; Kang KH; Min KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():953-959. PubMed ID: 31190782
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
    Brownridge DJ; Zaidi STR
    J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Cowan J; Gaudet L; Mulpuru S; Corrales-Medina V; Hawken S; Cameron C; Aaron SD; Cameron DW
    PLoS One; 2015; 10(11):e0142205. PubMed ID: 26558756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double-blind Controlled Trial.
    Beltaief K; Msolli MA; Zorgati A; Sekma A; Fakhfakh M; Marzouk MB; Boubaker H; Grissa MH; Methamem M; Boukef R; Belguith A; Bouida W; Nouira S
    Acad Emerg Med; 2019 Apr; 26(4):434-442. PubMed ID: 30156361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.
    Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J
    Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation.
    Ranieri P; Bianchetti A; Margiotta A; Virgillo A; Clini EM; Trabucchi M
    J Am Geriatr Soc; 2008 May; 56(5):909-13. PubMed ID: 18384582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors analysis for one-year and long-term mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease].
    Zhang Y; Lin YX
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):895-900. PubMed ID: 31826532
    [No Abstract]   [Full Text] [Related]  

  • 17. Associated factors, assessment, management, and outcomes of patients who present to the emergency department for acute exacerbation of chronic obstructive pulmonary disease: A scoping review.
    Phillips TM; Moloney C; Sneath E; Beccaria G; Issac H; Mullens AB; Gow J; Rana R; King A
    Respir Med; 2022 Mar; 193():106747. PubMed ID: 35086024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
    Moretti M; Fagnani S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.
    Crisafulli E; Ielpo A; Barbeta E; Ceccato A; Huerta A; Gabarrús A; Soler N; Chetta A; Torres A
    Respir Res; 2018 Dec; 19(1):261. PubMed ID: 30591055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Outcome after Chronic Obstructive Pulmonary Disease Exacerbations Requiring Non-invasive Ventilation during Hospitalization.
    Tokgoz Akyil F; Gunen H; Agca M; Gungor S; Yalcinsoy M; Sucu P; Akyil M; Sevim T
    Arch Bronconeumol; 2016 Sep; 52(9):470-6. PubMed ID: 27156204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.